A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
Clinical trial NCT06835530 · RECRUITING
Trial details
- NCT number
- NCT06835530
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-09
- Primary completion
- 2030-04-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.